ALPS Advisors’s Ardent Health ARDT Stock Holding History

ALPS Advisors’s Portfolio ARDT Stock Details ARDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-35,249	Closed	-$311K	–	1159
2025 Q4	$311K	Buy	35,249 +389	+1%	+$4.5K	﹤0.01%	936
2025 Q3	$462K	Buy	+34,860	New	+$436K	﹤0.01%	749

Other funds holding ARDT

CTC

Chai Trust Company Chicago, Illinois $1.18B AUM 19.62% 1-Year Est. Return

Ventas Inc Chicago, Illinois $80M AUM

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

ECM

ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return

ALPS Advisors's ARDT Position: Q1 2026 in Review

ALPS Advisors sold out of Ardent Health (ARDT) in Q1 2026, closing a stake of 35,249 shares — an estimated $311K sold.

ALPS Advisors first reported a position in ARDT in Q3 2025 and held it in 2 quarters. The position peaked at $462K in Q3 2025. 136 funds tracked by Wall St. Rank hold ARDT as of Q1 2026.

ALPS Advisors reported no remaining Ardent Health position as of Q1 2026 after selling out during the quarter.
ALPS Advisors sold 35,249 Ardent Health shares in Q1 2026, an estimated $311K.
ALPS Advisors first reported a position in Ardent Health in Q3 2025 and held it in 2 quarters.
ALPS Advisors's Ardent Health position peaked at $462K in Q3 2025.
136 funds tracked by Wall St. Rank held Ardent Health as of Q1 2026.

Based on ALPS Advisors's 13F filing for Q1 2026, filed 8 May 2026.